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Hypothesized risk factors for psychostimulant, amphetamine,
and cocaine abuse include dopamine (DA) receptor polymor-
phisms, HIV infection, schizophrenia, drug-induced paranoias,
and movement disorders; however, the molecular, cellular, and
biochemical mechanisms that predispose to drug sensitivity or
drive the development of addiction are incompletely under-
stood. Using the Borna disease rat, an animal model of viral-
induced encephalopathy wherein sensitivity to the locomotor
and stereotypic behavioral effects of D-amphetamine and co-
caine is enhanced (Solbrig et al., 1994, 1998), we identify a
specific neurotrophin expression pattern triggered by striatal
viral injury that increases tyrosine hydroxylase activity, an early
step in DA synthesis, to produce a phenotype of enhanced
amphetamine sensitivity. The reactive neurotrophin pattern pro-
vides a molecular framework for understanding how CNS viral
injury, as well as other CNS adaptations producing similar
growth factor activation profiles, may influence psychostimu-
lant sensitivity.
Key words: virus; encephalitis; neurotrophin; Borna disease;
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There is increasing experimental evidence to support a role for
neuronal growth factors in the CNS response to drug exposure
that outlasts the acute effects of drug. BDNF infusions into the
ventral tegmental area (VTA) or nucleus accumbens (NAc) en-
hance cocaine-induced locomotor activity and conditioned re-
ward in animal models (Horger et al., 1999). Factors neuro-
trophin-3 (NT-3) and basic FGF (bFGF) are increased in the
VTA by repeated administration of psychostimulants (Flores et
al., 1998; Pierce et al., 1999). Glial cell line-derived neurotrophin
factor (GDNF) knock-out mice have greater sensitivity to loco-
motor and behavioral effects of cocaine (Messer et al., 2000).
Growth factors, known to influence synaptic transmission (Bou-
langer and Poo, 1999), which act as sensitizing agents (Shu and
Mendell, 1999) and regulate neuronal morphology (Connor and
Dragunow, 1998), may mediate the increases in dendritic length,
dendritic spine density, and numbers of branched spines on me-
dium spiny neurons of the NAc that follow repeated
D-amphetamine (AMPH) or cocaine injections (Robinson and
Kolb, 1997, 1999).
Borna disease virus (BDV) is a negative-strand RNA virus
epidemiologically linked to patients with histories of intravenous
drug abuse (Bode et al., 1988) and to dopaminergic syndromes
such as schizophrenia (Hatalski et al., 1997). Adult rats infected
with BDV are sensitive to the locomotor and stereotypic behav-
ioral effects of D-amphetamine and cocaine (Solbrig et al., 1994,
1998), have specific pathology in monoaminergic, prefrontal, and
limbic circuits (Solbrig et al., 1994) and provide a unique exper-
imental model for exploring mechanisms by which persistent
CNS infection can modify psychostimulant sensitivity.
Drug sensitivity is one predictor of addiction vulnerability.
Because of the BD rat’s psychostimulant sensitivity, the CNS
adaptations to virus are presumed similar to the adaptations to
schedules of drug use that produce increases in amphetamine or
cocaine sensitivity. Thus, the BD rat is used to elucidate links
between cell physiology and reward circuit neuroadaptive mech-
anisms common to viral and repeated drug use insult.
Neurotrophins, which generate cascades of cytoplasmic signals,
potentially influence cytoplasmic protein mediators of psycho-
stimulant sensitivity through stimulated kinase reactions. One
target for neurotrophin signaling may be tyrosine hydroxylase
(TH) phosphorylation. TH is the rate-limiting step in dopamine
(DA) synthesis; enzymatic activity is enhanced by multiple ki-
nases acting at several phosphorylation sites. Increased TH activ-
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ity, in turn, would enhance dopaminergic pharmacological effects,
such as those of the indirect DA agonists D-amphetamine and
cocaine.
To test the hypothesis that neuronal growth factors contribute
to the enhanced behavioral response to D-amphetamine and
cocaine in BD rats, we examined neurotrophin transcript levels in
striatum (caudate putamen and nucleus accumbens) and mid-
brain (substantia nigra pars compacta plus ventral tegmental
area), neuropil microenvironments of DA termini and cell bodies,
respectively. Using pharmacological and biochemical techniques
to identify changes in DA synthetic steps, we suggest a specific
neurotrophin expression pattern is related to increased TH func-
tion in surviving dopaminergic terminals.
MATERIALS AND METHODS
Subjects. Four-week-old male Lewis rats (Charles River Laboratories,
Wilmington, MA) were intracerebrally infected with BDV by injection of
1.6 3 10 4 tissue culture infectious dose units, strain He/80–1, into the
right lateral ventricle (BD rats) (Solbrig et al., 1994) or sham-infected
with sterile PBS (NL rats). Six weeks later, infected rats and age-
matched, sham-infected rats were tested or killed. Animal care and
handling procedures were in compliance with institutional and National
Institutes of Health guidelines. All experimental protocols and proce-
dures were approved by the University of California-Irvine Institutional
Animal Care and Use Committee.
Tissue preparation. For nucleic acid, protein, and neurochemical anal-
yses, rats were decapitated, and brains were removed. The striatum
(caudate putamen and nucleus accumbens) was dissected from a 2-mm-
thick coronal section taken between 1 and 3 mm posterior to the anterior
genu of the corpus callosum. A 1-mm-thick coronal section was taken
through the mesencephalon at the superior colliculus, and a segment
containing the substantia nigra pars compacta (SNc) and VTA was
dissected from the ventral portion of this block.
RNase protection assay analysis. RNA was isolated from striatal and
mesencephalic regions homogenized in Tri-Reagent (Molecular Re-
search Center, Cincinnati, OH). Quantitation of neurotrophic factor
mRNAs was by multiprobe RNase Protection Assay (RPA) for rat
mRNA (RiboQuant Multi-Probe RPA System; PharMingen, San Diego,
CA). Probes were synthesized and labeled by transcription in the pres-
ence of [ 32P]UTP. RPAs were performed on 10 mg of total RNA using
an RPAIII kit (Ambion, Austin TX). Protected fragments were resolved
on a 5% denaturing polyacrylamide gel and analyzed using a Storm 840
PhosphorImager (Molecular Dynamics, Sunnyvale, CA). Host genes L32
and GAPDH transcript levels were used as controls (n 5 8 per group).
Electron microscopy. Anesthetized rats were perfused with 0.1 M
phosphate-buffered 4% paraformaldehyde, 0.5% glutaraldehyde, 0.25%
ethyl acetimidate, and 1 mM CaCl2. Brain tissue was removed, cut in 1
mm sections, post-fixed in 2% osmium tetroxide, block-stained in 4%
uranyl acetate, dehydrated in graded ethanols, embedded, sectioned, and
stained with uranyl acetate and lead citrate, and photographed at 25,000
or 50,0003 (Kadota and Kadota, 1979) (n 5 6 per group).
Drugs. Drugs used were a-methyl-para-tyrosine (amrt) methyl ester
(5, 10, 20 mg/kg, i.p.) (Sigma, St. Louis, MO) and D-amphetamine
sulfate (0.25, 0.50, 1.00 mg/kg, s.c.) (Sigma) (Weissman et al., 1966;
Cooper et al., 1972) dissolved in sterile saline.
Behavioral testing. A dose of amrt (20 mg/kg, i.p.) was established as
the lowest dose to suppress locomotor response to 1.0 mg/kg
D-amphetamine in four normal, uninfected rats. Thereafter, BD and
additional normal uninfected rats received the threshold (20 mg/kg, i.p.)
amrt dose, followed by one of three subcutaneous doses (0.25, 0.50, or
1.00 mg/kg) of D-amphetamine or its vehicle control 4 hr later. Animals
were tested during 3 hr testing sessions once per week. Behavior was
monitored continually in 40 3 25 3 20 cm cages equipped with two
equally spaced horizontal photocell beams across the long axis. Loco-
motor activity, quantified by numbers of cross-overs (the successive
interruption of two photobeams) (Solbrig et al., 1994) was plotted against
dose (n 5 7–8 per group). Comparison BD and normal groups received
only D-amphetamine.
TH protein determination. For Western blotting, isolated brain regions
were homogenized in (1:4 w/v) 220 mM sodium acetate, pH 6.15 (Hyland
et al., 1996). Ten micrograms of protein samples were size-fractionated
by 10% SDS-PAGE (Mini-Protean-3 cell system; Bio-Rad, Hercules,
CA). TH was quantified by Western blotting using rabbit anti-TH poly-
clonal antibody (AB151; Chemicon, Temecula, CA) at 1:5000 dilution, an
HRP-conjugated secondary antibody with an ECL-Plus detection system
(Amersham, Arlington Heights, IL), and phosphorimaging analysis
(Storm 840 PhosphorImager, Molecular Dynamics). Actin detected by
mouse anti-actin monoclonal antibody (MAB 1501; Chemicon) served as
a control for protein concentration loaded (n 5 4–6 per group).
For immunohistochemistry, anesthetized animals were perfused with
buffered 4% paraformaldehyde; brains were removed, post-fixed, and
cryoprotected. Twenty micromolar slide-mounted sections were immu-
nostained with rabbit anti-TH serum (Protos Biotech, New York, NY) at
1:1000, a biotinylated anti-rabbit secondary antibody, enhanced with
avidin-biotinylated enzyme complexes, and reacted in 3,39-
diaminobenzidine (DAB) (n 5 3 per group).
TH activity assay. TH activity was measured in soluble fractions of
isolated brain regions by HPLC detection of L-DOPA. Striatal and
mesencephalic sections were homogenized in (1:4 w/v) 10 mM potassium
phosphate, pH 7.4, then centrifuged at 14,000 3 g in 10K Nanosep tubes
(Pall Filtron Corporation, Northborough, MA). Seven hundred micro-
gram protein aliquots were incubated at 37°C for 10 min in 100 mM
sodium acetate buffer, pH 6, in the presence of: L-tyrosine, D,L-6-methyl-
5,6,7,8-tetrahydropterine-HCl (6MPH4) (Sigma), catalase (Boehringer
Mannheim), an aromatic L-amino acid decarboxylase inhibitor:
3-hydroxybenzylhydrazine 2HCl (NSD-1015) (Research Biochemicals,
Natick, MA), and ferrous ammonium sulfate (Naoi et al., 1988) (n 5 6–7
per group).
TH phosphorylation and immunoprecipitation. Neutralized acid extracts
of striatal brain homogenates were subjected to direct-back or indirect-
back phosphorylation (Guitart and Nestler, 1989). Twenty microgram
aliquots of neutralized supernatants were phosphorylated with 0.03 mg of
purified catalytic subunit of cAMP-dependent protein kinase (PKA-c)
(Sigma) or 5 U of PKA holoenzyme (Sigma) and 10 mM g 32P-ATP (10
Ci/mmol; DuPont NEN, Boston, MA).
TH was immunoprecipitated with rabbit anti-TH polyclonal antibody
(Chemicon) and Streptococcal Protein G (Sigma). 32P incorporation by
TH was quantified by phosphorimaging (Storm 840 PhosphorImager,
Molecular Dynamics). Duplicate immunoprecipitate samples were run
(n 5 4 per group).
Statistical analysis. Group differences in neurotrophin mRNA, TH
protein, and L-DOPA levels were analyzed by unpaired two-tailed t tests,
with significance set at p , 0.05. Separate BD and NL rat populations
were used for each experiment.
Behavioral data were analyzed for differences in response to
D-amphetamine and the suppressant effects of amrt in BD and normal
rats. Two-way ANOVA was performed with (BD or normal) group as the
independent variable and repeated measures on (D-amphetamine) dose.
Three-way ANOVA was performed with (infected or noninfected) group
and (amrt) treatment as the independent variables and repeated mea-
sures on (D-amphetamine) dose. Differences among groups or treatment
conditions were verified by simple main effects, post hoc Newman–Keuls,
or t tests.
Differences in levels of TH back phosphorylation, as percentages of
total phosphorylation per treatment group, were assessed by x 2 analysis.
RESULTS
Changes in neurotrophic factor expression accompany
degenerative changes in the striatum of BD rats
Neurotrophin transcript levels
To test the hypothesis that neuronal growth factors along DA
circuits contribute to the enhanced behavioral response to
D-amphetamine in BD rats, we examined neurotrophin transcript
levels in striatum and SNc. Striata of BD rats had significantly
increased levels of mRNAs for all tested members of the nerve
growth factor (NGF) family of growth factors (the neurotro-
phins): bNGF, BDNF, NT-3, and NT-4; a significant increase in
CNTF, a member of the neuropoietic cytokine family; and a
significant decrease in GDNF mRNA levels, a member of the
transforming growth factor family (Fig. 1A) (n 5 8 per group).
The changes in transcripts encoding neuronal growth factors
suggest widespread striatal plastic changes. BDNF, NT-3, NT-4,
and CNTF all have trophic effects on DA-producing cells in vitro
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(Hagg and Varon, 1993; Connor and Dragunow, 1998). No group
differences were found in neurotrophin mRNA content in SNc
(Fig. 1B).
Electron microscopy
Ultrastructural changes in striatum were examined to evaluate
integrity of axon terminals and synaptic sites related to DA
(symmetric) synapses. Electron micrographs of the striatum in
BD rats (Fig. 1C,D) showed degenerating axon terminals next to
postsynaptic spines with thick postsynaptic densities. Figure 1C
illustrates a degenerating axon terminal at the head of a dendritic
spine and a portion of a symmetric (DA) synapse on the neck of
the same spine. Figure 1D displays a vacated presynaptic site,
now occupied by glia (asterisk), a finding consistent with axon
terminal degeneration in this asymmetric (glutamatergic) syn-
apse. For comparison, asymmetric synapses in the striatum of a
normal uninfected rat appear in Figure 1E. Ultrastructural
changes observed in the BD rat striatum are consistent with
shifting distribution or survival of asymmetric (presumed excita-
tory, glutamatergic) and symmetric (presumed inhibitory, DA)
synapses on dendritic spines of striatal neurons and are reminis-
cent of the plastic changes at points of convergence of dopami-
nergic and glutamatergic inputs hypothesized to contribute to the
development of psychostimulant sensitization (White and Kali-
vas, 1998; Ghasemzadeh et al., 1999).
Increased TH activity is also found in the striatum
Behavioral pharmacology
Behavioral supersensitivity to D-amphetamine is illustrated by a
left shift in the D-amphetamine dose–response curve in BD rats
(Fig. 2A). There was a significant difference in D-amphetamine
locomotor activity by two-way ANOVA (group 3 AMPH dose,
F(3,21) 5 3.549; p , 0.05) with significant increase in locomotor
activity at 0.5 mg/kg dose for BD rats after BD dose main effect
(F(3,21) 5 3.689; p , 0.05).
Because growth factors have DA system maintenance and
enhancing effects, we next tested whether the enhanced behav-
ioral responses to D-amphetamine in BD rats (initially reported,
Solbrig et al., 1994) is because of increased activity of the DA
synthetic enzyme TH. Using pharmacological probes to block DA
synthesis, we examined the locomotor response to AMPH in the
presence of the TH inhibitor amrt. A 20 mg/kg (intraperitoneal)
dose of amrt was established as the lowest dose to suppress
locomotor response to 1.0 mg/kg D-amphetamine in four normal,
uninfected rats. Thereafter BD and additional normal uninfected
rats received the threshold (20 mg/kg, i.p.) amrt dose, followed
by one of three subcutaneous doses (0.25, 0.50, or 1.00 mg/kg) of
D-amphetamine or its vehicle control 4 hr later. The suppressant
effects of amrt were different in BD and normal rats. A significant
difference in the effect produced by amrt was revealed by three-
way ANOVA (group 3 treatment 3 AMPH dose; F(3,66) 5 2.755;
p , 0.05). Although amrt significantly attenuated AMPH-
induced locomotion in NL rats (1 mg/kg AMPH; F(1,11) 5 5.034;
p , 0.05) (Fig. 2B), there was no effect of amrt pretreatment in
BD rats (Fig. 2C).
TH protein and activity determination
The possibility that differences in TH metabolism might underlie
differences in the response to D-amphetamine was investigated by
examining basal TH protein levels by immunostaining and West-
ern blotting and HPLC measures of L-DOPA after timed reaction
of L-tyrosine with striatal protein extracts. BD rat striatal sections
had fewer stained TH-immunoreactive fibers in the striatum, less
intense staining of the fiber plexus, and greater prominence of
myelinated tracts, consistent with dearborization and contraction
of gray matter (data not shown). Levels of TH protein by Western
blotting were significantly reduced in striatum of BD rats [BD
(0.3023 6 0.0324) vs NL (0.5033 6 0.0583); t 5 3.009; df 5 1.6;
p , 0.05]. No group differences were found in TH content of SNc
(Fig. 3A) (n 5 4–6 per group).
TH activity was measured in soluble fractions of isolated brain
Figure 1. Regional neurotrophin expression and ultrastructure changes. A, B, Neurotrophic factor mRNAs were detected by multiprobe RPA
(RiboQuant Multi-Probe RPA System; PharMingen) and quantified by PhosphorImager densitometry. There were significant increases in bNGF, BDNF,
CNTF, NT-3, and NT-4 mRNA levels and a significant decrease in GDNF mRNA in the striatum of BD rats (A). SNc mRNA levels for neurotrophins
were similar in BD and NL rats (B). Values represent mean optical density in arbitrary units 6 SEM. Groups were compared by unpaired two-tailed
t tests with *p , 0.05, **p 5 0.001, and ***p , 0.0001, relative to normal uninfected rats (n 5 8 per group). C–E, Electron microscope study. Electron
micrographs of the striatum of BD rats with uranyl acetate and lead citrate staining, illustrating degenerating axon terminals (C, D, arrows), and glial
replacement of a presynaptic site (D, asterisk). In C, the degenerating axon terminal is at the head of a dendritic spine. Normal rat striatum is pictured
in E (photographed at 50,0003). Scale bar, 0.2 mm.
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regions by HPLC detection of L-DOPA. Despite significant re-
ductions in striatal TH protein levels, L-DOPA levels generated
by incubations of striatal protein extracts with L-tyrosine were
equivalent in BD and normal rats after 10 min incubations with
0.2 mM L-tyrosine [BD (98.29 6 8.11) vs NL (102.12 6 7.58);
t(1,11) 5 0.34; p 5 0.739] and increased, however, not significantly
[BD (284.45 6 24.02) vs NL (248.57 6 16.06); p . 0.05] in BD
striatal preparations after incubations with 2 mM L-tyrosine (Fig.
3B). No group differences were found in L-DOPA production of
SNc sections (n 5 6–8 per group).
Increased TH activity is related to
increased phospho-TH
TH phosphorylation and immunoprecipitation
TH phosphorylation at Ser40 correlates with increased TH activ-
ity in vivo; Phosphorylation at this site is dominated by cAMP-
dependent protein kinase A (PKA) (Haycock, 1990). TH phos-
phorylation status was examined, to determine the basis for
retention of normal TH enzymatic activity despite reduced TH
protein. Direct-back phosphorylation measures the dephospho
form of a phosphoprotein; indirect-back phosphorylation pro-
vides an index of total protein by means of complete phosphor-
Figure 2. Effect of amrt on AMPH-induced locomotor activity in noninfected (NL, panel B) and Borna-infected (BD, panel C) rats. Animals were tested
during 3 hr testing sessions once per week. Locomotor activity, quantified in activity cages by numbers of cross-overs (the successive interruption of 2
photobeams) (Solbrig et al., 1994) was plotted against dose. D-amphetamine locomotor activity was significantly increased in BD rats. Individual means
comparisons revealed a significant increase at 0.50 mg/kg dose (A). In normal rats, D-amphetamine-induced locomotion was significantly decreased in
the presence of 20 mg/kg amrt (B), whereas the same amrt dose failed to suppress D-amphetamine locomotor activity in BD rats (C). Values represent
mean (6 SEM) locomotor counts over 180 min. *p , 0.05 (n 5 7–8 per group).
Figure 3. TH protein and activity studies. A, Regional changes in levels of TH protein, detected by Western blot using rabbit polyclonal antibody to
TH (Chemicon AB151) and quantification by PhosphorImager densitometry. Levels of TH protein were significantly reduced in striatum of BD rats. No
group differences were found in TH content of SNc. Values represent mean optical density in arbitrary units 6 SEM. *p , 0.05 (two-tailed t test) (n 5
4–6 per group). B, L-DOPA generated by incubations of striatal and SNc protein extracts with L-tyrosine, detected by HPLC. Despite significant
reductions in striatal TH protein in BD rats (A), no group differences were observed in the production of L-DOPA after 10 min incubations with 2 mM
L-tyrosine and 700 mg of striatal protein. Values represent L-DOPA produced (in picomoles per minute per milligram protein) 6 SEM. No group
differences were found in L-DOPA production of SNc sections (n 5 6–8 per group). C, TH phosphorylation by PKA in vitro. Striatal protein extracts
were incubated with 10 mM g32P-ATP (10 Ci/mmol; NEN) and 0.03 mg of purified catalytic subunit of cAMP-dependent protein kinase (PKA-c) (Sigma),
immunoprecipitated with anti-TH polyclonal antisera (Chemicon), size-fractionated by SDS-PAGE, and subjected to autoradiography and densitometric
analysis. Levels of phospho-TH in striatum, produced by direct-back phosphorylation by the active catalytic subunit of PKA (PKA-c), were significantly
lower in the BD rats (66%; direct /indirect-back phosphorylation) versus 98% (direct /indirect-back phosphorylation) in NL group; x2 5 3.075; p , 0.05
(top panel ). Results shown with these specimens are representative of results with other animals and consistent with increased basal phosphorylation at
the Ser40 site in BD rats (see Results). A 1.75 times higher 32P incorporation by 5 U of PKA holoenzyme (Sigma) in BD rat direct-back phosphorylated
specimens, indicated by immunoreactive bands (bottom panel ), suggests the presence of elevated levels of cAMP to activate PKA.
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ylation. Higher basal phosphorylation status results in a lower
percentage of direct-back to indirect-back phosphorylation (Gui-
tart and Nestler, 1989; Guitart et al., 1990). Levels of phospho-
TH, produced by direct-back phosphorylation by the active cat-
alytic subunit of PKA (PKA-c), were significantly lower in striatal
brain homogenates of BD rats (66%; direct /indirect-back phos-
phorylation) versus 98% (direct /indirect-back phosphorylation)
in NL group x25 3.075, p , 0.05 (Fig. 3C, top image), consistent
with increased baseline levels of phospho-TH. Unexpectedly high
32P incorporation was also found in the presence of (holoenzyme)
PKA in the BD direct-back phosphorylation samples, suggesting
the presence of elevated cAMP levels for the activation of PKA
(Fig. 3C, bottom image). BD and normal uninfected samples had
no intrinsic PKA activity, because no P incorporation was seen in
protein extracts without PKA (data not shown). There were no
significant differences in back phosphorylation in SNc samples
treated with PKA-c or PKA (holoenzyme).
DISCUSSION
BDV infection of rats has pharmacological and lesion effects that
result in behavioral sensitivity to psychostimulants. In this model
of striatal injury, a specific neurotrophin expression pattern is
associated with augmented DA synthetic activity.
One hypothesis to explain the mechanism of increased TH
activity observed in the pharmacological and biochemical exper-
iments is increased activity of neuronal growth factors of the
NGF and neuropoietic cytokine families. Recently, BDNF and
NGF were found to elevate cAMP and PKA in regenerating
dorsal root ganglia cell cultures (Cai et al., 1999). Similarly, the
capture and concentration of diffusable growth factors with cyclic
nucleotide modulatory effects by presynaptic DA terminals could
increase levels of activated PKA and increase basal TH activity
derived from the TH Ser40 site. Our data are consistent with
increases in basal TH phosphorylation at the Ser40 site, although
phosphorylation at other sites by excess PKA has not been ex-
cluded. Evaluation of TH Ser31 site will be important because an
NGF-sensitive phosphorylation site at TH Ser31 has been dem-
onstrated on PC12 cells (Haycock et al., 1992). CNTF as well may
have the ability to act or collaborate with other growth factors at
the Ser31 site. The increase and prolongation of MAP kinase
(ERK1 and 2) activity reported for differentiating sympathetic
neurons in vitro by CNTF (Ip et al., 1994) may be relevant for the
BD model, because ERKs phosphorylate TH at Ser31, a cellular
response that would also enhance TH activity. Less predictable
for enzymatic activity and expression of the syndrome is GDNF,
whose transcripts are decreased in the striatum of BD rats. That
GDNF uses two signaling pathways, the Ras/MAPK and phos-
phatidylinositol 3-kinase (PI3-kinase) pathways (Trupp et al.,
1999), may prove important to understanding the biological and
behavioral significance of its decrease in the BD rat.
We postulate that a specific neurotrophin expression pattern
favors the development of drug sensitivity in the BD rat; the
DA-enhancing effects of the neurotrophin and neuropoietic cy-
tokine families are combined with the withdrawal of a protective
role for GDNF. As drugs of abuse are recognized to have their
own growth factor-enhancing effects, understanding the dynamics
between neurotrophin and neurotransmitter systems and the op-
timum neurotrophin profile for clinical effects will provide insight
into mechanisms of drug sensitivity, vulnerability, and addiction,
and provide targets for therapeutic intervention. BDV has been
linked to patients with psychiatric and drug abuse histories. The
possibility that viral infection can mimic aspects of vulnerability
to drug addiction raises the possibility that a history of viral
challenge itself could result in enhanced vulnerability to drug
addiction and speaks to models for future investigation of envi-
ronmental insult, CNS adaptation, and drug addiction.
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